{"id":"https://openalex.org/W4361910076","doi":"https://doi.org/10.1158/1078-0432.22450695","title":"Supplementary Figure 1 from Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer","display_name":"Supplementary Figure 1 from Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361910076","doi":"https://doi.org/10.1158/1078-0432.22450695"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22450695","doi":"https://doi.org/10.1158/1078-0432.22450695","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450695","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Biomarker_Analysis_of_Neoadjuvant_Doxorubicin_Cyclophosphamide_Followed_by_Ixabepilone_or_Paclitaxel_in_Early-Stage_Breast_Cancer/22450695/1/files/39901773.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Biomarker_Analysis_of_Neoadjuvant_Doxorubicin_Cyclophosphamide_Followed_by_Ixabepilone_or_Paclitaxel_in_Early-Stage_Breast_Cancer/22450695/1/files/39901773.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110480128","display_name":"Christine E. Horak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine E. Horak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021113979","display_name":"Lajos Pusztai","orcid":"https://orcid.org/0000-0001-9632-6686","observed_orcids":["https://orcid.org/0000-0001-9632-6686"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lajos Pusztai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081758381","display_name":"Guan Xing","orcid":"https://orcid.org/0000-0001-6011-3267","observed_orcids":["https://orcid.org/0000-0001-6011-3267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guan Xing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109050994","display_name":"Ovidiu C. Trifan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ovidiu C. Trifan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082195410","display_name":"Cristina Saura","orcid":"https://orcid.org/0000-0001-8296-5065","observed_orcids":["https://orcid.org/0000-0001-8296-5065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Saura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055292882","display_name":"Ling\u2010Ming Tseng","orcid":"https://orcid.org/0000-0002-4648-6646","observed_orcids":["https://orcid.org/0000-0002-4648-6646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling-Ming Tseng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056471340","display_name":"Stephen Y.T. Chan","orcid":"https://orcid.org/0000-0001-8865-6618","observed_orcids":["https://orcid.org/0000-0001-8865-6618","https://orcid.org/0000-0001-8998-5480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043714971","display_name":"Rosanne Welcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosanne Welcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"David Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-iii-tubulin","display_name":"TUBB3","score":0.9470000267028809},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.7940000295639038},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/doxorubicin-and-cyclophosphamide","display_name":"doxorubicin-cyclophosphamide","score":0.9419999718666077},{"id":"https://openalex.org/keywords/ixabepilone","display_name":"ixabepilone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7570000290870667},{"id":"https://openalex.org/keywords/mrna-expression","display_name":"mRNA expression","score":0.9409999847412109},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.6970000267028809},{"id":"https://openalex.org/keywords/protein-expression-correlation","display_name":"protein expression correlation","score":0.460999995470047}],"concepts":[{"id":"https://openalex.org/C2779194965","wikidata":"https://www.wikidata.org/wiki/Q11711607","display_name":"Ixabepilone","level":5,"score":0.965208113193512},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8564502000808716},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.7373510003089905},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6873371601104736},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.6284506320953369},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5976608395576477},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5950378179550171},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5904284715652466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5900947451591492},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.5703554153442383},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4690200388431549},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.451826274394989},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37545037269592285},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2778729498386383},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.23219385743141174},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.21755871176719666},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22450695","doi":"https://doi.org/10.1158/1078-0432.22450695","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450695","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Biomarker_Analysis_of_Neoadjuvant_Doxorubicin_Cyclophosphamide_Followed_by_Ixabepilone_or_Paclitaxel_in_Early-Stage_Breast_Cancer/22450695/1/files/39901773.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22450695.v1","doi":"https://doi.org/10.1158/1078-0432.22450695.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22450695.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22450695","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Biomarker_Analysis_of_Neoadjuvant_Doxorubicin_Cyclophosphamide_Followed_by_Ixabepilone_or_Paclitaxel_in_Early-Stage_Breast_Cancer/22450695","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22450695","doi":"https://doi.org/10.1158/1078-0432.22450695","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22450695","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Biomarker_Analysis_of_Neoadjuvant_Doxorubicin_Cyclophosphamide_Followed_by_Ixabepilone_or_Paclitaxel_in_Early-Stage_Breast_Cancer/22450695/1/files/39901773.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361910076.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4235249871","https://openalex.org/W2320235510","https://openalex.org/W2099734281","https://openalex.org/W4361944448","https://openalex.org/W2132144873","https://openalex.org/W2321039541","https://openalex.org/W2068720278","https://openalex.org/W2314789986","https://openalex.org/W2604270673","https://openalex.org/W2085520037"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"50K,":[3],"Correlation":[4],"between":[5],"\u03b2III-tubulin":[6,26],"IHC":[7],"(Saura":[8],"et":[9],"al.":[10],"manuscript":[11],"in":[12],"preparation)":[13],"and":[14],"mRNA":[15,27],"expression":[16],"data.":[17],"*Median":[18],"cut-off":[19],"used":[20],"to":[21],"determine":[22],"high":[23],"versus":[24],"low":[25],"expression.":[28],"IHC,":[29],"immunohistochemistry.":[30]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}